Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 1515983)

Published in Cancer on September 01, 1992

Authors

W Fischbach1, W Kestel, T Kirchner, J Mössner, K Wilms

Author Affiliations

1: Medizinische Poliklinik, University of Würzburg, Germany.

Articles by these authors

(truncated to the top 100)

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99

Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19

Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun (1997) 3.71

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78

Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum (2001) 2.66

Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65

Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63

Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin's lymphoma. German Gastrointestinal Lymphoma Study Group. Gastrointest Endosc (1999) 2.49

CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23

[A 32-year-old patient with diarrhoea and acute kidney failure]. Internist (Berl) (2006) 2.02

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology (2000) 2.02

Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73

Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67

Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66

The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64

Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62

Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60

Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut (2005) 1.59

Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer (2000) 1.56

Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54

Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer (2011) 1.46

Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology (2000) 1.43

[Chronic pancreatitis]. Dtsch Med Wochenschr (2008) 1.41

Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2000) 1.40

[Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder]. Z Gastroenterol (2005) 1.40

Limited value of positron emission tomography in treatment of pancreatic cancer: surgeon's view. World J Surg (2001) 1.39

Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol (1996) 1.37

Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst (1999) 1.36

The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res (2000) 1.36

High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33

Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology (2000) 1.30

Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28

Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med (2000) 1.27

The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26

Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21

Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20

Late pulmonary metastasis in uterine PEComa. J Clin Pathol (2003) 1.20

Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med (2001) 1.18

Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat (1998) 1.17

Epidemiology of Whipple's disease in Germany. Analysis of 110 patients diagnosed in 1965-95. Scand J Gastroenterol (1997) 1.16

Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol (1999) 1.14

Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol (2007) 1.14

Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut (1997) 1.13

Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch (1996) 1.10

Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10

Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1996) 1.09

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306. Ann Oncol (2012) 1.08

Esophageal intramural pseudodiverticulosis: endoscopic diagnosis and therapy. Dis Esophagus (2013) 1.07

Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol (1985) 1.07

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer (2012) 1.07

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol (2014) 1.07

Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes (1985) 1.04

Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today (1998) 1.04

Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology (1994) 1.03

A CDE/CHR tandem element regulates cell cycle-dependent repression of cyclin B2 transcription. FEBS Lett (2000) 1.03

Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc (1981) 1.03

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer (2002) 1.03

Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol (1998) 1.02

[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol (2012) 1.02

Primary amyloidosis of the mesentery and the retroperitoneum presenting with lymphedema. Am J Gastroenterol (1998) 1.01

Pseudoappendicitis caused by Plesiomonas shigelloides. J Clin Microbiol (1988) 1.01

Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol (2000) 1.00

A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma. Ann Oncol (2000) 1.00

The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial. Int J Cancer (2011) 0.99

Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression. Verh Dtsch Ges Pathol (2007) 0.99

Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis. Am J Respir Cell Mol Biol (1999) 0.99

[Molecular pathologic KRAS mutation analysis. A prerequisite of effective antibody treatment for metastasized colorectal cancer]. Chirurg (2008) 0.98

p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A. Oncogene (2006) 0.98

Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol (2001) 0.98

Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum (1998) 0.98

Cerebral air embolism after gastroduodenoscopy: complication of a duodenocaval fistula. Gastrointest Endosc (1994) 0.97

Influence of treatment with pancreatic extracts on pancreatic enzyme secretion. Gut (1989) 0.97

Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clin Infect Dis (1997) 0.96

Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy. Anticancer Res (2003) 0.95

Epithelial-mesenchymal transdifferentiation and extracellular matrix gene expression in pleomorphic adenomas of the parotid salivary gland. J Pathol (1998) 0.95

A Herpes saimiri oncogene causing peripheral T-cell lymphoma in transgenic mice. Oncogene (1996) 0.95

Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol (2000) 0.95

Age-related changes in human cervical, thoracal and lumbar intervertebral disc exhibit a strong intra-individual correlation. Eur Spine J (2011) 0.95

Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology (1997) 0.95

Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol (1997) 0.95

[Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study]. Dtsch Med Wochenschr (2004) 0.94

Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology (1989) 0.94

[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]. Verh Dtsch Ges Pathol (2000) 0.94

Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for RT-PCR in the detection of isolated tumor cells. Lab Invest (2001) 0.93

7-Deaza-2'-deoxyguanosine allows PCR and sequencing reactions from CpG islands. Mol Pathol (2002) 0.93

Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci U S A (1995) 0.93

Ultrastructural localization of type VI collagen in normal adult and osteoarthritic human articular cartilage. Osteoarthritis Cartilage (2002) 0.93

Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.93

Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology (1999) 0.93

Effective isolation of high-quality total RNA from human adult articular cartilage. Anal Biochem (2000) 0.93

Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol (1987) 0.93

Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillofac Surg (1998) 0.92

Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study. FEMS Immunol Med Microbiol (1999) 0.92

Neurofibromatosis presenting as a severe systemic vasculopathy. Eur J Pediatr (1994) 0.92

Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol (1989) 0.92